T1DM Flashcards

1
Q

what is the definition of T1DM

A

usually leads to absolute insulin deficiency, for most part caused by auto-immune process of varying severity occurring within pancreatic beta-cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the risk factors for developing T1DM

A

age, sex, race, genotype, possibly geographic location & seasonality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the relation between age and T1DM

A

85% T1DM in under 20s, peak between 1014 y/o, but 25% are diagnosed as adults
(so not disease specific to young)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe the relation between sex and T1DM

A

M=F in young, but in Europe M>F after puberty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the relation between genotype and T1DM

A

increased influence of environmental factors
HLA genes represent ~50% familial risk of T1DM
highest risk is DR3-DQ2/DR4-DQ8, confers 19 fold increased risk
(95% diagnosed under 30y/o have one of these genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some possible environmental/accelerating factors for T1DM

A

viral infection, maternal factors, weight gain, vitamin D, puberty, stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what % of people in Scotland with diabetes have T1DM

A

10.7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the pathophysiology behind T1DM

A

auto-immune disease, lymphocytes attack islets of Langerhans and subsequently beta-cells causing insulin secretory defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what auto-antibodies are tested for in diagnoses of T1DM

A

GAD 65ab, IA-2AB, ZnT8AB

if all 3 +ve chance of T1DM >95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are some of the clinical features of T1DM

A

raised glucose, ketones, decreased insulin, decreased beta-cell mass and decreased C-peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what tests are sued to initially diagnose diabetes(not what type)

A

fasting glucose >/= 7mmol/L
random >/= 11mmol/L
and symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what tests are used to identify if someone has type 1 diabetes

A

often diagnosed on history and presentation(eg DKA) alone

if any doubt GAD/IA2 antibodies and C peptide may help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a typical clinical presentation for someone with type 1 diabetes

A

pre-school/peri-puberty, small peak in early 30s, usually lean, acute onset, severe symptoms, severe weight loss, ketonuria +/- metabolic acidosis, no evidence of microvascular disease diagnosis, immediate and permanent requirement for insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is LADA

A

latent autoimmune diabetes of adults
late onset T1DM, probably quite common in ‘typical’ T2DM patients
ketosis = T1DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what HbA1c range can be sued to diagnose T1DM

A

can’t use HbA1c to diagnose T1DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are some of the symptoms people with diabetes can present with

A

thirst, polyuria, thrush, weakness/fatigue, blurred vision, infections, weight loss, keto-acidosis

17
Q

when should hospitalisation be considered in diabetes presentation

A

DKA, significant ketonaemia, vomiting

18
Q

what are the aims of T1DM therapy

A

prevent hyperglycaemia, avoid hypoglycaemia and reduce chronic complications

19
Q

what is involved in the management of newly diagnosed T1DM patients

A

BG and ketone monitoring, insulin usually basal bolus regime, carb estimate, regular dietician contact, education about self-management(ie DAFNE)

20
Q

what is involved in the annual review assessment of T1DM patients

A

weight, BP, bloods(HbA1c, renal function, lipids), retinal screening, foot risk assessment

21
Q

describe the action of prandial insulin analogues, and give an example

A

onset action 10-15 mins, peak action 60-90mins, duration 4-5hrs
example = NovoRapid

22
Q

what is the benefit of an analogue basal insulin over an isophane basal insulin, and give an example of each

A
analogue = longer duration of action, less peak activity(flatter profile), can be given once or twice a day
example = Lantus(analogue), Insulatard(isophane)
23
Q

describe how most T1DM patients should be treated with insulin

A

multiple daily injections(3/4 daily) or CSII(insulin pump), educated how to match prandial insulin dose to carb intake, most should use insulin analogues(reduce hypoglycaemia risk)

24
Q

what situations decrease the likelihood of someone having T1DM, ie is it wrong diagnosis

A

diabetes diagnosed <6months old, detectable insulin production >/= 3years after diagnosis, undetectable pancreatic antibodies at diagnosis

25
Q

what are some associated auto-immune conditions with T1DM

A

thyroid disease, coeliac disease, pernicious anaemia, Addison’s disease, IgA deficiency